These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8918694)

  • 1. Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein.
    Lo-Man R; Martineau P; Manoury-Schwartz B; Hofnung M; Leclerc C
    Int Immunol; 1996 Aug; 8(8):1245-55. PubMed ID: 8918694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
    Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C
    J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope.
    Lo-Man R; Martineau P; Hofnung M; Leclerc C
    Eur J Immunol; 1993 Nov; 23(11):2998-3002. PubMed ID: 8223877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics.
    Leclerc C; Charbit A; Martineau P; Deriaud E; Hofnung M
    J Immunol; 1991 Nov; 147(10):3545-52. PubMed ID: 1719080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominance of a recombinant T-cell epitope depends on its molecular environment.
    Leclerc C; Martineau P; Charbit A; Lo-Man R; Dériaud E; Hofnung M
    Mol Immunol; 1993 Dec; 30(17):1561-72. PubMed ID: 8247026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein.
    Martineau P; Leclerc C; Hofnung M
    Mol Immunol; 1996 Dec; 33(17-18):1345-58. PubMed ID: 9171894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
    Martineau P; Guillet JG; Leclerc C; Hofnung M
    Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
    Lo-Man R; Martineau P; Hofnung M; Leclerc C
    Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.
    Lo-Man R; Langeveld JP; Dériaud E; Jehanno M; Rojas M; Clément JM; Meloen RH; Hofnung M; Leclerc C
    Infect Immun; 2000 Jun; 68(6):3079-89. PubMed ID: 10816447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of genetically engineered active maltose-binding proteins, including an immunogenic viral epitope insertion.
    Rodseth LE; Martineau P; Duplay P; Hofnung M; Quiocho FA
    J Mol Biol; 1990 Jun; 213(4):607-11. PubMed ID: 1694248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to hybrid maltose-binding proteins.
    O'Callaghan D; Martineau P; Fayolle C; Leclerc C; Guillet JG; Charbit A; Hofnung M
    Vaccine; 1993; 11(2):140-2. PubMed ID: 7679863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.
    Charbit A; Martineau P; Ronco J; Leclerc C; Lo-Man R; Michel V; O'Callaghan D; Hofnung M
    Vaccine; 1993 Sep; 11(12):1221-8. PubMed ID: 8256503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodominance does not result from peptide competition for MHC class II presentation.
    Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
    J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein.
    Coëffier E; Clément JM; Cussac V; Khodaei-Boorane N; Jehanno M; Rojas M; Dridi A; Latour M; El Habib R; Barré-Sinoussi F; Hofnung M; Leclerc C
    Vaccine; 2000 Nov; 19(7-8):684-93. PubMed ID: 11115689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.
    Leclerc C; Lo-Man R; Charbit A; Martineau P; Clément JM; Hofnung M
    Int Rev Immunol; 1994; 11(2):123-32. PubMed ID: 7519229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
    LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M
    J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.
    Campbell DJ; Serwold T; Shastri N
    J Immunol; 2000 Jan; 164(1):168-75. PubMed ID: 10605008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the in vivo behavior of CD4+ T cells specific for an antigen expressed in Escherichia coli.
    Chen ZM; Jenkins MK
    J Immunol; 1998 Apr; 160(7):3462-70. PubMed ID: 9531307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rate of dissociation between antibody and antigen determines the efficiency of antibody-mediated antigen presentation to T cells.
    Guermonprez P; England P; Bedouelle H; Leclerc C
    J Immunol; 1998 Nov; 161(9):4542-8. PubMed ID: 9794380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved epitope-specific T cell activation by recombinant Bet v 1-MBP fusion proteins.
    van Neerven RJ; Sparholt SH; Schou C; Larsen JN
    Clin Exp Allergy; 1998 Apr; 28(4):423-33. PubMed ID: 9641568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.